Eton Pharmaceuticals, Inc. (ETON) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
ETON EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ETON Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 53.5% | -1.1% | -5.8% |
| 2024 | 60.0% | -6.7% | -9.8% |
| 2023 | 66.6% | -3.8% | -3.0% |
| 2022 | 67.4% | -38.9% | -42.4% |
| 2021 | 88.0% | -6.8% | -9.0% |
Download Data
Export ETON earnings history in CSV or JSON format
Free sign-in required to download data
Eton Pharmaceuticals, Inc. (ETON) Earnings Overview
As of May 8, 2026, Eton Pharmaceuticals, Inc. (ETON) reported trailing twelve-month net income of -$5M, reflecting -13.3% year-over-year growth. The company earned $-0.17 per diluted share over the past four quarters, with a net profit margin of -5.8%.
Looking at the long-term picture, ETON's historical earnings data spans multiple years. The company achieved its highest annual net income of -$936,000 in fiscal 2023.
Eton Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRAX (-$327M net income), AVDL (-$278,000 net income, -28.9% margin), TLRY (-$2.95B net income, -266.3% margin), ETON has comparable earnings metrics. Compare ETON vs PRAX →
ETON Earnings vs Peers
Earnings metrics vs comparable public companies
ETON Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | -20.4% | $-844,000 | $-0.17 | -5.8% | -1.1% |
| 2024 | -$4M | -308.4% | -$3M | $-0.15 | -9.8% | -6.7% |
| 2023 | $-936,000 | +89.6% | -$1M | $-0.04 | -3.0% | -3.8% |
| 2022 | -$9M | -361.4% | -$8M | $-0.36 | -42.4% | -38.9% |
| 2021 | -$2M | +93.0% | -$1M | $-0.08 | -9.0% | -6.8% |
| 2020 | -$28M | -52.7% | -$27M | $-1.33 | -71717.9% | -69515.4% |
| 2019 | -$18M | -43.8% | -$19M | $-1.02 | -1910.3% | -1939.6% |
| 2018 | -$13M | -78.0% | -$10M | $-1.99 | - | - |
| 2017 | -$7M | - | -$7M | $-0.41 | - | - |
See ETON's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ETON Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ETON vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonETON — Frequently Asked Questions
Quick answers to the most common questions about buying ETON stock.
Is ETON growing earnings?
ETON EPS fell to $-0.17, with earnings declining -13.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-5M.
What are ETON's profit margins?
Eton Pharmaceuticals, Inc. net margin is -5.8%, with operating margin at -1.1%. Below-average margins reflect competitive or cost pressures.
How consistent are ETON's earnings?
ETON earnings data spans 2017-2025. The declining earnings trend is -13.3% YoY. Historical data enables comparison across business cycles.